Inherited thrombophilia and pregnancy loss-epidemiology

Thrombosis Research

Volumn 115, Issue SUPPL., 2005, Pages 13-17

  Cohen, H ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLENETETRAHYDROFOLIC ACID; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBOXANE;

APOPTOSIS; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CONFERENCE PAPER; DYSFIBRINOGENEMIA; FETUS DEATH; FETUS WASTAGE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; INHERITANCE; PHENOTYPE; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; THROMBOELASTOGRAPHY; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 12544258194     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Stirling Y, Woolf L, North WR, et al. Haemostasis in normal pregnancy. Thromb Haemost 1984;52:176-82.
2. Cumming AM, Tait RC, Fildes S, et al. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995;90:725-7.
3. Bowles L, Cohen H. Inherited thrombophilias and anticoagulation in pregnancy. Ballieres Best Pract Res Clin Haematol 2003;17(3):471-89.
4. Wright JG, Cooper P, Astedt B, et al. Fibrinolysis during normal human pregnancy: complex inter-relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clotlysis time. Br J Haematol 1988;69:253-8.
5. McColl MD, Ramsay JE, Tait RC, et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost 1997;78:1183-8.
6. Gerhardt A, Scharfe RE, Beckmann MW, et al. Prothrombinand factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374-80.
7. Brill-Edwards P, Ginsberg JS, Gent M, et al. Safety of withholding heparin in pregnany women with a history of venous thromboembolism. N Engl J Med 2000;343:1430-44.
8. Rai R, Shlebak A, Cohen H. Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Human Reprod 2001;16:961-5.
9. Galli M, Barbui T. Antiphospholipid antibodies and pregnancy. Ballieres Best Pract Res Clin Haematol 2003;16:211-25.
10. Stirrat GM. Recurrent miscarriage. Lancet 1990;336:673-5.
11. Clifford K, Rai R, Watson H, et al. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Human Reprod 1995;10:495-694.
12. Jody L, Kujovic MD. Thrombophilia and pregnancy complications. Amer J Obstet Gynaecol 2004;191:412-24.
13. Rey E, Kahn S, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-8.
14. Meinardi JR, Middeldorp S, de Kam PJ, et al. Increased risk for fetal loss in carriers of factor V Leiden mutation. Ann Intern Med 1999;130:736-9.
15. Tormene D, Simioni P, Prandoni, et al. The risk of fetal loss in family members of probands with factor V Leiden mutation. Thromb Haemost 1999;82:1237-9.
16. Dizon-Townson DS, Meline L, Nelson LM, et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Amer J Obstet Gynecol 1997;177:402-5.
17. Younis JS, Brenner B, Ohel G, et al. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. Amer J Reprod Immunol 2000;43:31-5.
18. Sarig G, Younis JS, Hoffman R, et al. Thrombophilia is common is women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002;77:342-7.
19. Gris JC, Ripart-Neveu S, Maugard C, et al. Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study. Thromb Haemost 1997;77:103-1096.
20. Marietta M, Facchinettti F, Sgarbi L, et al. Elevated levels of factor VIII in women with early recurrent miscarriage. Thromb Haemost 2003;12:2536-9.
21. Haverkate F, Samama M. Familial dysfibrinogenaemia and thrombophilia: report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995;97:551-4.
22. Nelen WL, Blom HJ, Steegers EA, et al. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000 (Dec);74(6):1196-9.
23. Gris JC, Quere I, Monpeyroux F, et al. Casecontrol study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nîmes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 1999;81:891-9.
24. Sanson BJ, Friederich PW, Simioni, et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996;75:387-8.
25. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
26. Vossen CY, Preston FE, Conard J, et al. Hereditary thrombophilia and fetal loss: a prospective follow-up study. Journal of Thromb Haemost 2004;2:296-592.
27. Vincent T, Rai R, Regan L, et al. Increased thrombin generation in women with recurrent miscarriage. Lancet 1998;352:116.
28. Tulpalla M, Viinikka L, Ylikorkaka O. Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet 387:879.
29. Woodhams BJ, Candotti G, Shaw R, et al. Changes in coagulation and fibrinolysis during pregnancy: evidence of activation of coagulation preceding spontaneous abortion. Thromb Res 1989;55:99-107.
30. Rai R, Tuddenham E, Backos M, et al. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Human Reprod 2003;18:2540-3.
31. Healy AM, Rayburn HB, Rosenberg RD, et al. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci U S A 1995;92:850-4.
32. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Human Reprod 2000;15:1830-3.
33. Burton GJ, Jauniaux E, Watson AL. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited. Amer J Obstet Gynaecol 181:718-24.
34. Isermann B, Sood R, Pawlinsky R, et al. The thrombomodulin-protein C system is essential for maintenance of pregnancy. Nat Med 2003;9:331-7.
35. Rai R, Backos M, Elgaddal S, et al. Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. Human Reprod 2002;17:442-5.
36. Carp H, Dolitzky M, Tur-Kaspa I, et al. Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage. Fertil Steril 2002;78:58-62.
37. Brenner B, Grabowski EF, Hellgren M, et al. Thrombophilia and pregnancy complications. Thromb Haemost 2004;92:678-81.